UNVERIFIEDSingle SourceSTAT+: Gossamer lung disease drug fails late-stage study, but company will still seek FDA approvalStat News|2/23/2026
UNVERIFIEDSingle SourceSTAT+: NIH redefines ‘clinical trials,’ dividing researchers Stat News|2/12/2026
UNVERIFIEDSingle SourceOpinion: My granddaughter has a rare disease. But clinical trials often exclude patients like herStat News|2/11/2026
UNVERIFIEDSingle SourceFrom Croatia to MAHA: How an unapproved drug became the next hot peptideStat News|2/3/2026